Wilbanks Smith & Thomas Asset Management LLC lessened its holdings in shares of Castlight Health Inc (NYSE:CSLT) by 39.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,910 shares of the software maker’s stock after selling 27,940 shares during the quarter. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Castlight Health were worth $161,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CSLT. Schwab Charles Investment Management Inc. boosted its stake in Castlight Health by 25.5% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 249,281 shares of the software maker’s stock worth $1,035,000 after purchasing an additional 50,687 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Castlight Health by 52.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 222,660 shares of the software maker’s stock worth $924,000 after acquiring an additional 77,011 shares during the period. Alliancebernstein L.P. raised its holdings in shares of Castlight Health by 19.0% during the 2nd quarter. Alliancebernstein L.P. now owns 95,750 shares of the software maker’s stock worth $397,000 after acquiring an additional 15,300 shares during the period. Teachers Advisors LLC raised its holdings in shares of Castlight Health by 55.7% during the 2nd quarter. Teachers Advisors LLC now owns 113,462 shares of the software maker’s stock worth $471,000 after acquiring an additional 40,579 shares during the period. Finally, TIAA CREF Investment Management LLC raised its holdings in shares of Castlight Health by 58.5% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 171,275 shares of the software maker’s stock worth $711,000 after acquiring an additional 63,243 shares during the period. 43.39% of the stock is currently owned by institutional investors.

Several research analysts have recently commented on the company. Zacks Investment Research lowered Castlight Health from a “buy” rating to a “hold” rating in a report on Thursday, February 1st. Cantor Fitzgerald upgraded Castlight Health from a “neutral” rating to an “overweight” rating and set a $5.00 price target on the stock in a report on Tuesday, January 30th. BidaskClub lowered Castlight Health from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th. Canaccord Genuity reiterated a “buy” rating and set a $7.00 price target on shares of Castlight Health in a report on Thursday, October 26th. Finally, Chardan Capital reduced their price target on Castlight Health from $6.50 to $6.30 and set a “buy” rating on the stock in a report on Thursday, October 26th. Three analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $5.11.

In related news, CFO Mangini Siobhan Nolan sold 8,866 shares of the business’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.70, for a total value of $32,804.20. Following the sale, the chief financial officer now directly owns 78,561 shares in the company, valued at approximately $290,675.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO John C. Doyle sold 13,686 shares of the business’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the sale, the chief executive officer now owns 123,705 shares in the company, valued at $458,945.55. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,778 shares of company stock worth $84,411. 24.38% of the stock is owned by insiders.

Castlight Health Inc (NYSE CSLT) opened at $3.45 on Wednesday. Castlight Health Inc has a fifty-two week low of $3.05 and a fifty-two week high of $4.75. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.94 and a current ratio of 1.94.

ILLEGAL ACTIVITY NOTICE: This report was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://theolympiareport.com/2018/02/14/wilbanks-smith-thomas-asset-management-llc-sells-27940-shares-of-castlight-health-inc-cslt.html.

Castlight Health Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Want to see what other hedge funds are holding CSLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Castlight Health Inc (NYSE:CSLT).

Institutional Ownership by Quarter for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.